Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Rating) Director Linda Grais bought 10,000 shares of the stock in a transaction that occurred on Monday, May 15th. The shares were bought at an average cost of $2.45 per share, with a total value of $24,500.00. Following the completion of the transaction, the director now owns 10,000 shares […]